These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 80421)

  • 21. Trinitrophenyl modification of H-2k and H-2b spleen cells results in enhanced serological detection of Kk-like determinants.
    Levy RB; Dower SK; Shearer GM; Segal DM
    J Exp Med; 1984 May; 159(5):1464-72. PubMed ID: 6201586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on in vivo priming to TNP-reactive cytotoxic effector cell system. II. Augmented secondary cytotoxic response by radioresistant T cells and demonstration of differential helper activity as a function of the stimulating dose of TNP-self.
    Fujiwara H; Shearer GM
    J Immunol; 1980 Mar; 124(3):1271-6. PubMed ID: 6965689
    [No Abstract]   [Full Text] [Related]  

  • 23. Properties of H-2L locus products in allogeneic and H-2 restricted, trinitrophenyl-specific cytotoxic responses.
    Levy RB; Shearer GM; Hansen TD
    J Immunol; 1978 Dec; 121(6):2263-9. PubMed ID: 82579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining cytolytic T lymphocyte recognition of chemically modified self. I. Response to trinitrophenyl-H-2Kk.
    Handa K; Herrmann S
    J Immunol; 1985 Sep; 135(3):1564-72. PubMed ID: 2410495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human cytotoxic response in vitro to trinitrophenyl-modified autologous cells. II. Diversity of self determinants recognized in association with TNP.
    Shaw S; Shearer GM
    J Immunol; 1978 Jul; 121(1):290-9. PubMed ID: 78944
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo immunisation and reaction against TNP-modified splenocytes.
    Bischoff P; Oth D
    Nature; 1978 Aug; 274(5673):806-8. PubMed ID: 683318
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of shared H-2Kk and H-2Dk antigens that function as self determinants for cell-mediated lympholysis to trinitrophenyl-self.
    Fujiwara H; Levy RB; Shearer GM
    J Immunol; 1981 Apr; 126(4):1522-5. PubMed ID: 6162891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on in-vivo priming of the trinitrophenyl-reactive cytotoxic effector-system. III. Are helper T cells involved in the in-vitro generation of cross-reactive as well as restricted cytotoxic responses?
    Fujiwara H; Levy RB; Shearer GM
    Immunobiology; 1982 Feb; 160(5):472-8. PubMed ID: 6978282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic T lymphocytes induced against allogeneic I-region determinants react with Ia molecules on trinitrophenyl-conjugated syngeneic target cells.
    Billings P; Burakoff S; Dorf ME; Benacerraf B
    J Exp Med; 1977 Aug; 146(2):623-8. PubMed ID: 69009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes.
    Shearer GM
    Eur J Immunol; 1974 Aug; 4(8):527-33. PubMed ID: 4547153
    [No Abstract]   [Full Text] [Related]  

  • 31. Generation of cytotoxic T lymphocytes against TNP-haptenated syngeneic cells in microcultures: the effect of nude spleen cells as accessory cells.
    Wolf M; Suessmuth W; Reddehase M; Droege W
    Cell Immunol; 1981 Aug; 62(2):385-95. PubMed ID: 6974607
    [No Abstract]   [Full Text] [Related]  

  • 32. Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by H-2K and H-2D serological regions of the murine major histocompatibility complex.
    Shearer GM; Rehn TG; Garbarino CA
    J Exp Med; 1975 Jun; 141(6):1348-64. PubMed ID: 47900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of virus-specific modifications recognized by cytotoxic T cells is not altered by prior substitution of target cells with trinitrophenol.
    Biddison WE; Snodgrass HR; Bennink J; Effros RB; Doherty PC
    J Exp Med; 1977 Aug; 146(2):617-22. PubMed ID: 69008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of a clonal assay for cytotoxic T lymphocytes to determine the Ly phenotypes of the cytotoxic precursor and effector cells to alloantigens and trinitrophenyl-modified self antigens.
    Teh HS; Teh SJ
    J Immunol; 1980 Nov; 125(5):1977-86. PubMed ID: 6159396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of both I-A and I-E/C subregion antigens on accessory cells required for in vitro generation of cytotoxic T lymphocytes against alloantigens or TNBS-modified syngeneic cells.
    Pettinelli CB; Ahmann GB; Shearer GM
    J Immunol; 1980 Apr; 124(4):1911-6. PubMed ID: 6154084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major histocompatibility complex products restrict the adherence of cytolytic T lymphocytes to minor histocompatibility antigens or to trinitrophenyl determinants on schistosomula of Schistosoma mansoni.
    Vadas MA; Butterworth AE; Burakoff S; Sher A
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1982-5. PubMed ID: 88051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell types required for H-2-restricted cytotoxic responses generated by trinitrobenzene sulfonate-modified syngeneic cells or trinitrophenyl-conjugated proteins.
    Pettinelli CB; Schmitt-Verhulst AM; Shearer GM
    J Immunol; 1979 Mar; 122(3):847-54. PubMed ID: 87418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. H-2 haplotype specificity of molecular requirements for trinitrophenyl recognition by anti-hapten cytotoxic T lymphocytes.
    Hale AH; McGee MP
    Cell Immunol; 1981 Feb; 58(1):147-55. PubMed ID: 6261964
    [No Abstract]   [Full Text] [Related]  

  • 39. Dendritic cells are accessory cells for the development of anti-trinitrophenyl cytotoxic T lymphocytes.
    Nussenzweig MC; Steinman RM; Gutchinov B; Cohn ZA
    J Exp Med; 1980 Oct; 152(4):1070-84. PubMed ID: 6968335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNP-modified syngeneic cells enhance immunoregulatory T cell activities similar to allogeneic effects.
    Eastman AY; Lawrence DA
    J Immunol; 1982 Feb; 128(2):926-31. PubMed ID: 6459388
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.